Evaluación del impacto de antimicrobianos tras la aparición del virus Sars-Cov-2 en las distintas áreas del Hospital el Pino
No hay miniatura disponible
Archivos
Fecha
2024
Autores
Profesor/a Guía
Facultad/escuela
Idioma
es
Título de la revista
ISSN de la revista
Título del volumen
Editor
Universidad Andrés Bello
Nombre de Curso
Licencia CC
Licencia CC
Resumen
Introducción: La pandemia por covid-19 obligó a poner a prueba estrategias para superar esta crisis sanitaria. Debido a la gravedad del cuadro clínico por covid-19, es que se tomaron medidas estrictas, para mejorar el pronóstico de cada paciente como lo fue la decisión de usar antibióticos como tratamiento frente a una infección prematura, o para coinfecciones. - Objetivo: Evaluar el impacto del uso de antimicrobianos y corticoides en contexto de pandemia Covid-19 en el año 2020 en comparación con el año 2019 sin presencia del virus, a través de herramientas comparativas como dosis diaria definida (DDD), datos microbiológicos y base de datos de consumo de frascos, provenientes de los distintos servicios del Hospital el Pino. - Metodología: Los registros del consumo de antibióticos, antimicóticos y corticoides provienen de la base de datos Novasist usada por el Hospital el Pino. Los datos microbiológicos de bacterias y Hongos se extrajeron del laboratorio de microbiología y sin datos sensibles correspondientes a pacientes. Todos los valores del consumo de medicamentos y los datos microbiológicos fueron organizados cuantitativamente en tablas Excel, ordenados y separados por servicio y año. Posteriormente se calculó la dosis diaria definida (DDD) para cada medicamento.
Resultados: Cada medicamento analizado arrojo valores de consumo distintos
para cada servicio al igual que corticoides y antimicóticos los que obtuvieron
resultados de la misma índole, distintos para cada evidenciando una tendencia
al aumento en algunos de ellos. Así mismo, bacterias y hongos, también
presentaron resultados que variaron según cada servicio y año.
- Conclusión: Hay un evidente aumento en el consumo de ciertos antibióticos,
corticoides y antimicóticos que no se ve reflejado para todos los medicamentos
al calcular las DDD/100 camas. Bacterias y hongos si evidenciaron un aumento,
pero debido a las condiciones provocadas por la pandemia, es difícil atribuirla al
aumento del consumo específicamente por el Covid-19
Introduction: The covid-19 pandemic forced us to test strategies to overcome this health crisis. Due to the severity of the clinical picture due to Covid-19, strict measures were taken to improve the prognosis of each patient, such as the decision to use antibiotics as a treatment for premature infection or for co-infections. - Objective: To evaluate the impact of the use of antimicrobials and corticosteroids in the context of the Covid-19 pandemic in 2020 compared to 2019 without the presence of the virus, through comparative tools such as defined daily dose (DDD), microbiological data and Bottle consumption database, coming from the different services of the El Pino Hospital. - Methodology: The records of the consumption of antibiotics, antifungals and corticosteroids come from the Novasist database used by Hospital el Pino. The microbiological data of bacteria and fungi were extracted from the microbiology laboratory and without sensitive data corresponding to patients. All drug consumption values and microbiological data were quantitatively organized in Excel tables, sorted and separated by service and year. Subsequently, the defined daily dose (DDD) was calculated for each medication. - Results: Each medication analyzed showed different consumption values for each service, as well as corticosteroids and antifungals, which obtained results of the same nature, different for each, evidencing an increasing trend in some of them. Likewise, bacteria and fungi also presented results that varied according to each service and year. - Conclusion: There is an evident increase in the consumption of certain antibiotics, corticosteroids and antifungals that is not reflected for all medications when calculating the DDD/100 beds. Bacteria and fungi did show an increase, but due to the conditions caused by the pandemic, it is difficult to attribute it to the increase in consumption specifically due to Covid-19
Introduction: The covid-19 pandemic forced us to test strategies to overcome this health crisis. Due to the severity of the clinical picture due to Covid-19, strict measures were taken to improve the prognosis of each patient, such as the decision to use antibiotics as a treatment for premature infection or for co-infections. - Objective: To evaluate the impact of the use of antimicrobials and corticosteroids in the context of the Covid-19 pandemic in 2020 compared to 2019 without the presence of the virus, through comparative tools such as defined daily dose (DDD), microbiological data and Bottle consumption database, coming from the different services of the El Pino Hospital. - Methodology: The records of the consumption of antibiotics, antifungals and corticosteroids come from the Novasist database used by Hospital el Pino. The microbiological data of bacteria and fungi were extracted from the microbiology laboratory and without sensitive data corresponding to patients. All drug consumption values and microbiological data were quantitatively organized in Excel tables, sorted and separated by service and year. Subsequently, the defined daily dose (DDD) was calculated for each medication. - Results: Each medication analyzed showed different consumption values for each service, as well as corticosteroids and antifungals, which obtained results of the same nature, different for each, evidencing an increasing trend in some of them. Likewise, bacteria and fungi also presented results that varied according to each service and year. - Conclusion: There is an evident increase in the consumption of certain antibiotics, corticosteroids and antifungals that is not reflected for all medications when calculating the DDD/100 beds. Bacteria and fungi did show an increase, but due to the conditions caused by the pandemic, it is difficult to attribute it to the increase in consumption specifically due to Covid-19
Notas
Seminario (Químico Farmacéutico)
Palabras clave
Antibióticos, Antimicóticos, Corticosteroides, Evaluación, 2019 y 2020